News: NTI Neurotech International Completes A$10.0 Million Capital Raise, page-6

Given that there have already been Cannabis type Medicines approved before for other uses,
I would think that this should be able to get to market fairly quickly !!!!

Given they have completed Phase II/III Trials,
It's really only approval then sales as the next steps.

This would be the general stage where Big Pharma Interest and Take Overs often Occur.

This is because all the testing and development has already been done,
So they can make a Partnership, Licensing or Take-Over Offer.

Big Pharma Co's have the manufacturing and Distribution Networks ready to go,
And know what the market is worth.

Some may have an inferior product on the market,
And see that what NTI is offering is superior to what they are selling.
They then could consider making a Take-Over, Partnership or Licensing Offer.

For example Gilead has just paid US$ 4.3B ($6.67 Billion AUD) for an as yet to be proven drug as an additive therapy to its liver disease portfolio.

Anyhow this could well be snapped up by a Big Pharma Co,
For something in the Billions of $$$$ Range,
given the size of the markets it can treat and,
it's proven safety profile....